ZINC FORMATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	2CHO2.Zn
Molecular Weight	155.444
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Zn++].[O-]C=O.[O-]C=O

InChI

InChIKey=XOBMCBQSUCOAOC-UHFFFAOYSA-L

InChI=1S/2CH2O2.Zn/c2*2-1-3;/h2*1H,(H,2,3);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	Zn
Molecular Weight	65.409
Charge	2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	CHO2
Molecular Weight	45.0174
Charge	-1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.alfa.com/en/catalog/B24210/ | https://cameochemicals.noaa.gov/chemical/4812 | https://www.ncbi.nlm.nih.gov/pubmed/8583799

Zinc formate is a white crystalline solid. It is soluble in water. The primary hazard is the threat to the environment. Immediate steps should be taken to limit its spread to the environment. It is used as a catalyst in chemical processing and as a waterproofing agent. Zinc formate is used as a pharmaceutical intermediate. Synthetic and plant-derived zinc formate were equally effective as inhibitors of cytochrome P-450 enzymes and as hepatoprotective agents in carbon tetrachloride-treated rats.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Cytochrome P-450, rat 1 Target ID: Cytochrome P-450, rat Sources: https://www.ncbi.nlm.nih.gov/pubmed/8583799	Inhibitor 8504

Conditions

Condition	Modality	Targets	Highest Phase	Product
Liver diseases 15 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8583799	Primary		Basic research	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Temperature- and pressure-dependent studies of niccolite-type formate frameworks of [NH3(CH2)4NH3][M2(HCOO)6] (M = Zn, Co, Fe).	2016-10-05	27711614
Raman and IR studies of pressure- and temperature-induced phase transitions in [(CH2)3NH2][Zn(HCOO)3].	2014-12-01	25398085
Mononuclear Phenolate Diamine Zinc Hydride Complexes and Their Reactions With CO2.	2014-03-10	24882918
Systematic first principles parameterization of force fields for metal-organic frameworks using a genetic algorithm approach.	2009-02-05	19133795
Solvent effects on the structural and formyl substrate reactivity properties of a nitrogen/sulfur-ligated zinc hydroxide complex.	2006-05-15	16676971
Theoretical Study on the Mechanism of Formation of Cyanate Resins.	1999-06-25	11674547

Patents

Sample Use Guides

In Vivo Use Guide

Rats: Groups of 3 rats were administered 1 ml of water or 10 mg/ml zinc formate solution daily by gastric lavage for 3 days.

Route of Administration: Other

In Vitro Use Guide

Zinc formate (0.25 - 2.50 mg/ml) dose-dependently inhibited rat liver microsomal aminopyrine-N-demethylase activity.

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:21:41 GMT 2025` Edited by `admin` on `Mon Mar 31 21:21:41 GMT 2025`
Record UNII	ZZ67G2CT75
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FORMIC ACID, ZINC SALT (2:1)

Preferred Name

English

ZINC FORMATE

Systematic Name

English

ZINC DIFORMATE

Systematic Name

English

ZINC FORMATE [MI]

Common Name

English

Classification Tree Code System Code

EPA PESTICIDE CODE

87802